Ghent University Academic Bibliography

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474

Add to list

Hyaluronic acid conjugates of TLR7/8 agonists for targeted delivery to secondary lymphoid tissue

Euna Yoo, Alex CD Salyer, Michael JH Brush, Yupeng Li, Kathryn L Trautman, Nikunj M Shukla, Ans De Beuckelaer (UGent) , Stefan Lienenklaus, Kim Deswarte (UGent) , Bart Lambrecht (UGent) , et al.

(2018) BIOCONJUGATE CHEMISTRY. 29(8). p.2741-2754

Add to list

Journal Article
A1
open access

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Alexander Van Parys (UGent) , Peter Vandenabeele (UGent) , Johan Grooten (UGent) , Jan Tavernier (UGent) , Stefaan De Koker (UGent) and Xavier Saelens (UGent)

(2018) NATURE COMMUNICATIONS. 9.

Add to list

Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs

Eline Abma (UGent) , Kathelijne Peremans (UGent) , Filip De Vos (UGent) , Tim Bosmans (UGent) , Adriaan Kitshoff (UGent) , Sylvie Daminet (UGent) , Y Ni, Robrecht Dockx (UGent) and Hilde De Rooster (UGent)

(2018) VETERINARY AND COMPARATIVE ONCOLOGY. 16(3). p.318-323

Add to list

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles

Nadine Leber, Leonard Kaps, Misbah Aslam, Jonathan Schupp, Alexander Brose, David Schäffel, Karl Fischer, Mustafa Diken, Dennis Strand, Kaloian Koynov, et al.

(2017) JOURNAL OF CONTROLLED RELEASE. 248. p.10-23

Add to list

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Geneviève Garcin, Jennyfer Bultinck (UGent) , Franciane Paul, Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yann Bordat, Dominiek Catteeuw (UGent) , Lode De Cauwer (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 7(3).

Add to list

Transiently responsive block copolymer micelles based on N-(2-hydroxypropyl)methacrylamide engineered with hydrolyzable ethylcarbonate side chains

Sabah Kasmi (UGent) , Benoit Louage (UGent) , Lutz Nuhn (UGent) , Alexandra Van Driessche (UGent) , Jan Van Deun (UGent) , Izet Karalic (UGent) , Martijn Risseeuw (UGent) , Serge Van Calenbergh (UGent) , Richard Hoogenboom (UGent) , Riet De Rycke (UGent) , et al.

(2016) BIOMACROMOLECULES. 17(1). p.119-127

Add to list

Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles

Yu I Svenskaya, AM Pavlov, DA Gorin, DJ Gould, Bogdan Parakhonskiy (UGent) and GB Sukhorukov

(2016) COLLOIDS AND SURFACES B-BIOINTERFACES. 146. p.171-179

Add to list

Journal Article
A1
open access

The tumor suppressor Hace1 is a critical regulator of TNFR1-mediated cell fate

Luigi Tortola, Roberto Nitsch, Mathieu Bertrand (UGent) , Melanie Kogler, Younes Redouane, Ivona Kozieradzki, Iris Uribesalgo, Lilian M Fennell, Mads Daugaard, Helene Klug, et al.

(2016) CELL REPORTS. 15(7). p.1481-1492

Add to list

Journal Article
A1
open access

Strain prioritization and genome mining for enediyne natural products

Xiaohui Yan, Huiming Ge, Tingting Huang, Dong Yang, Qihui Teng, Ivana Crnovčić, Xiuling Li, Jeffrey D Rudolf, Jeremy R Lohman, Yannick Gansemans (UGent) , et al.

(2016) MBIO. 7(6).

Academic Bibliography

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Hyaluronic acid conjugates of TLR7/8 agonists for targeted delivery to secondary lymphoid tissue

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Transiently responsive block copolymer micelles based on N-(2-hydroxypropyl)methacrylamide engineered with hydrolyzable ethylcarbonate side chains

Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles

The tumor suppressor Hace1 is a critical regulator of TNFR1-mediated cell fate

Strain prioritization and genome mining for enediyne natural products

Contents

Support

Contact